TWiV 829: Antiviral and cytotoxically empowered for COVID-19
Nov 14, 2021•1 hr 44 min•Ep. 829
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
A TWiV duo reviews how SARS-CoV-2 attacks the olfactory mucosa but spares the olfactory bulb, vaccination with BNT162b2 induces virus-specific stem cell memory T cells, and development of an oral protease inhibitor for the treatment of COVID-19.
Hosts: Vincent Racaniello and Brianne Barker
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- How SARS-CoV-2 attacks olfactory mucosa (Cell)
- SARS-CoV-2-specific stem cell memory T cells after mRNA vaccine (Sci Immunol)
- Oral SARS-CoV-2 protease inhibitor (Science)
- Paxlovid phase 2/3 trial preliminary results (Pfizer)
- Letters read on TWiV 829
- Timestamps by Jolene. Thanks!
Brianne – Coronavirus Neutralizing Antibodies and mRNA Vaccine Video
Vincent – MHC restriction of cytotoxic T cell lysis (Nobel description)
Lisa – Shall Furnish Medicine
Bistra – Saving the World by Julia Alvarez
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast